http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103327996-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6489 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103327996-B |
| titleOfInvention | Thrombolysis composition and comprise its angiostenosis or the medicine for treatment agent composition of occlusive disease |
| abstract | The present invention relates to a kind of the medicine for treatment agent composition, the thrombolytic therapy of step of this thrombolysis composition that comprises administration and the methods for the treatment of of angiostenosis or occlusive disease that comprise the thrombolysis composition of the peptide with Arg-Gly-Asp die body, the angiostenosis comprising this thrombolysis composition or occlusive disease. The composition of the present invention and method adopt integrates element target principle in the thrombus such as platelet surface GPIIb-IIIa, instead of adopts existing Plasminogen activation principle, thus has the advantage of the thrombus that effective decomposition has generated. Further, the composition of the present invention and method no longer cause restenosis after through, also effectively open capillary blood vessel, and have neuroprotective efficacy. |
| priorityDate | 2010-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.